A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition
Status:
Completed
Trial end date:
2013-07-15
Target enrollment:
Participant gender:
Summary
This is an open-label, crossover, randomized, single dose, three treatments, three periods
and six sequences, single dosage, balanced study to determine Bioequivalence of Isotretinoin.
Bioequivalence will be compared between the reference medication one (T1) vs the test
medication (T3): (T1 vs T3); and the reference medication two (T2), vs test medication (T3):
(T2 vs T3). Finally, treatments T1 vs T2 will be compared statistically to determine if they
are bioequivalent.